19-19120082-T-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_017814.3(TMEM161A):ā€‹c.1288A>Gā€‹(p.Thr430Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000258 in 1,587,996 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000085 ( 0 hom., cov: 33)
Exomes š‘“: 0.000019 ( 2 hom. )

Consequence

TMEM161A
NM_017814.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.29
Variant links:
Genes affected
TMEM161A (HGNC:26020): (transmembrane protein 161A) Involved in several processes, including cellular response to UV; regulation of response to DNA damage stimulus; and response to retinoic acid. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07799178).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TMEM161ANM_017814.3 linkuse as main transcriptc.1288A>G p.Thr430Ala missense_variant 12/12 ENST00000162044.14 NP_060284.1 Q9NX61-1
TMEM161ANM_001411131.1 linkuse as main transcriptc.1213A>G p.Thr405Ala missense_variant 12/12 NP_001398060.1
TMEM161ANM_001256766.3 linkuse as main transcriptc.979A>G p.Thr327Ala missense_variant 10/10 NP_001243695.1 Q9NX61-2
TMEM161AXM_047439023.1 linkuse as main transcriptc.1237A>G p.Thr413Ala missense_variant 12/12 XP_047294979.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TMEM161AENST00000162044.14 linkuse as main transcriptc.1288A>G p.Thr430Ala missense_variant 12/121 NM_017814.3 ENSP00000162044.7 Q9NX61-1

Frequencies

GnomAD3 genomes
AF:
0.0000855
AC:
13
AN:
152080
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000791
AC:
16
AN:
202390
Hom.:
1
AF XY:
0.0000733
AC XY:
8
AN XY:
109188
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000409
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000386
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000341
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000195
AC:
28
AN:
1435916
Hom.:
2
Cov.:
37
AF XY:
0.0000211
AC XY:
15
AN XY:
711790
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000370
Gnomad4 ASJ exome
AF:
0.0000783
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000121
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000273
Gnomad4 OTH exome
AF:
0.0000505
GnomAD4 genome
AF:
0.0000855
AC:
13
AN:
152080
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
8
AN XY:
74276
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000720
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000718
ExAC
AF:
0.00000831
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 11, 2022The c.1288A>G (p.T430A) alteration is located in exon 12 (coding exon 12) of the TMEM161A gene. This alteration results from a A to G substitution at nucleotide position 1288, causing the threonine (T) at amino acid position 430 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
13
DANN
Benign
0.81
DEOGEN2
Benign
0.036
.;T;T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.55
T;T;T
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.078
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.96
.;L;.
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.3
N;N;.
REVEL
Benign
0.039
Sift
Benign
0.43
T;T;.
Sift4G
Benign
0.28
T;T;T
Polyphen
0.0010
.;B;.
Vest4
0.083
MutPred
0.73
.;Loss of glycosylation at T430 (P = 0.0425);.;
MVP
0.081
MPC
0.27
ClinPred
0.020
T
GERP RS
2.4
Varity_R
0.087
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs774442685; hg19: chr19-19230891; API